Mei-Jie Zhang

Author PubWeight™ 106.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007 6.93
2 Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol 2010 4.67
3 Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood 2011 3.02
4 A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model. Comput Methods Programs Biomed 2007 2.60
5 Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 2005 2.44
6 Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. Blood 2008 2.34
7 Alzheimer Disease: evaluation of a functional MR imaging index as a marker. Radiology 2002 2.27
8 Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood 2002 2.19
9 Extensions and applications of the Cox-Aalen survival model. Biometrics 2003 1.96
10 Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program. Biol Blood Marrow Transplant 2007 1.89
11 Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma. Biol Blood Marrow Transplant 2013 1.88
12 Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study. Biol Blood Marrow Transplant 2011 1.88
13 Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 2006 1.82
14 Flexible competing risks regression modeling and goodness-of-fit. Lifetime Data Anal 2008 1.82
15 Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. Biol Blood Marrow Transplant 2012 1.72
16 Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS). Blood 2013 1.71
17 Outcome of transplantation for myelofibrosis. Biol Blood Marrow Transplant 2009 1.68
18 Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood 2006 1.67
19 Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide. Biol Blood Marrow Transplant 2008 1.67
20 Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. J Clin Oncol 2008 1.63
21 Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality. J Clin Oncol 2013 1.59
22 A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. Biol Blood Marrow Transplant 2006 1.58
23 Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure. Biol Blood Marrow Transplant 2011 1.57
24 Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia. Blood 2012 1.57
25 NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation. Biol Blood Marrow Transplant 2010 1.56
26 SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models. Comput Methods Programs Biomed 2010 1.56
27 Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning. Biol Blood Marrow Transplant 2008 1.51
28 Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning. Biol Blood Marrow Transplant 2012 1.46
29 Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. Blood 2006 1.44
30 Access to hematopoietic stem cell transplantation: effect of race and sex. Cancer 2010 1.43
31 Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission. Biol Blood Marrow Transplant 2011 1.29
32 Comparing treatments in the presence of crossing survival curves: an application to bone marrow transplantation. Biometrics 2008 1.27
33 A semiparametric random effects model for multivariate competing risks data. Biometrika 2010 1.22
34 A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR. Biol Blood Marrow Transplant 2009 1.22
35 Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry. Blood 2004 1.18
36 Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. Blood 2004 1.16
37 Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses. Br J Haematol 2003 1.15
38 Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 2009 1.14
39 Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis. Blood 2011 1.13
40 Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma. Br J Haematol 2009 1.13
41 Regression models for hazard rates versus cumulative incidence probabilities in hematopoietic cell transplantation data. Biol Blood Marrow Transplant 2006 1.12
42 Analyzing Competing Risk Data Using the R timereg Package. J Stat Softw 2011 1.08
43 Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. J Clin Oncol 2006 1.06
44 Marginal models for clustered time-to-event data with competing risks using pseudovalues. Biometrics 2011 1.05
45 Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents. Biol Blood Marrow Transplant 2009 1.04
46 Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma. Biol Blood Marrow Transplant 2009 1.00
47 A proportional hazards regression model for the subdistribution with right-censored and left-truncated competing risks data. Stat Med 2011 1.00
48 Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research. Br J Haematol 2006 0.98
49 HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. Biol Blood Marrow Transplant 2008 0.95
50 The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes. Biol Blood Marrow Transplant 2009 0.92
51 The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006 0.91
52 Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study. Clin Lymphoma Myeloma Leuk 2010 0.90
53 Pairwise multiple comparison adjustment in survival analysis. Stat Med 2005 0.89
54 Asymptotic theory for the Cox semi-Markov illness-death model. Lifetime Data Anal 2007 0.89
55 Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome. Biol Blood Marrow Transplant 2013 0.88
56 Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies. Biol Blood Marrow Transplant 2011 0.87
57 Comparison of twin and autologous transplants for multiple myeloma. Biol Blood Marrow Transplant 2008 0.87
58 A class of goodness of fit tests for a copula based on bivariate right-censored data. Biom J 2005 0.87
59 Simplified validated prognostic model for progression-free survival after autologous transplantation for hodgkin lymphoma. Biol Blood Marrow Transplant 2013 0.86
60 Increased whole blood viscosity associated with arterial stiffness in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2014 0.84
61 Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. Biol Blood Marrow Transplant 2006 0.84
62 The additive risk model for estimation of effect of haplotype match in BMT studies. Scand Stat Theory Appl 2011 0.84
63 Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 2013 0.84
64 Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens. Blood 2014 0.83
65 Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation. Biol Blood Marrow Transplant 2008 0.83
66 Transplantation conditioning regimens and outcomes after allogeneic hematopoietic cell transplantation in children and adolescents with acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2012 0.82
67 CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin. Biol Blood Marrow Transplant 2007 0.81
68 Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children. Biol Blood Marrow Transplant 2010 0.80
69 The outcomes of family haploidentical hematopoietic stem cell transplantation in hematologic malignancies are not associated with patient age. Biol Blood Marrow Transplant 2010 0.80
70 Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement. Br J Haematol 2013 0.80
71 Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis. J Clin Oncol 2004 0.79
72 HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR. Biol Blood Marrow Transplant 2007 0.79
73 Competing risks with missing covariates: effect of haplotypematch on hematopoietic cell transplant patients. Lifetime Data Anal 2012 0.79
74 A Mass Redistribution Algorithm for Right Censored and Left Truncated Time to Event Data. J Stat Plan Inference 2009 0.77
75 The use of group sequential designs with common competing risks tests. Stat Med 2012 0.76
76 Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome. Pediatr Blood Cancer 2014 0.76
77 Checking Fine and Gray subdistribution hazards model with cumulative sums of residuals. Lifetime Data Anal 2014 0.75
78 Autologous stem cell transplantation for small cell lung cancer. Biol Blood Marrow Transplant 2002 0.75
79 Guest editor introduction to issue on transplant statistics. Lifetime Data Anal 2008 0.75
80 Editorial: To the memory of John P. Klein. Lifetime Data Anal 2015 0.75